Inhibitory effects of theophylline and procaterol on eosinophil function

Internal Medicine

Volumn 36, Issue 4, 1997, Pages 276-282

  Okubo, Yoshio ^a   Hossain, Mahboob ^a   Horie, Shiro ^a   Momose, Tomoyasu ^a   Suzuki, Jun Ichi ^a   Isobe, Mitsuaki ^a   Sekiguchi, Mode ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adhesion molecule; Degranulation; Drug; Leukocyte

Indexed keywords

PROCATEROL; THEOPHYLLINE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CONTROLLED STUDY; DEGRANULATION; DOSE RESPONSE; DRUG EFFECT; DRUG MIXTURE; DRUG SCREENING; EOSINOPHIL; HUMAN; HUMAN CELL; NORMAL HUMAN;

EID: 0030752848     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.276     Document Type: Article

References (32)

1. Guillol C, Fornaris M, Badier M, Orehek J, Spontaneous and provoked resistance to isoproterenol in isolated human bronchi. J Allergy Clin Immunol 74: 713, 1984.
2. Louis RE, Radermecker MF, Substance Pinduced histarnine release from human basophils, skin and lung fragments: effect of nedocromil sodium and theophylline. Int Arch Allergy Appl Immunol 92: 329, 1990.
3. Kita H, Abu-Ghazaleh RI, Gleich GJ, Abraham RT. Regulation of Iginduced eosinophil degranulation by adenosine 3',V-cyclic monophosphate. J Immunol 146: 2712, 1991.
4. Yukawa T, Kroegel C, Dent G, Chanez P, et al. Effect of theophylline and adenosine on eosinophil function. Am Rev Respir Dis 140: 327, 1989.
5. Calhoun WJ, Stevens CA, Lambert SB, Modulation of Superoxide production of alveolar macrophages and peripheral blood mononuclear cells by beta-agonists and theophylline. J Lab Clin Med 117: 514, 1991.
6. Barnes PJ, Rodger IW, Thomson NC. Asthma: basic mechanisms and clinical management. 2nd Edition. Academic Press, p. 527, 1992.
7. 2:-adrenoreceptor agonist terbutaline. Allergy 39: 351, 1984.
8. Munoz NM, Vita AJ, Neeley SP, et al. Beta adrenergic modulation of formyl-methionine-leucine-phenylalanine-stimulated secretion of eosinophil peroxidase and leukotriene C4. J Pharmacol Exp Ther 268: 139, 1994.
9. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD)and asthma. Am Rev Respir Dis 136: 225, 1987.
10. Barnes PJ, Cytokines as mediators of chronic asthma. Am J Respir Crit Care Med 150: S42, 1994.
11. Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR. Activation of CD4*T cells, increased Th2-type cytokine mRN A expression, and eosinophil recruitment in bronchoalvcolar lavage alter allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 92: 313, 1993.
12. Holgate ST, The 1992 Cournand Lecture. Asthma: past, present and future. Eur Respir J 6: 1507. 1993.
13. Horie S, Kita H, CDI Ib/CD18 (Mach is required for degranulation of human eosinophils induced by human recomhinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor. J Immunol 152: 5457, 1994.
14. Hansel TT, De Vries IJ, Carballido JM, et al. Induction and function of eosinophil intercellular adhesion molecule-1 and HLA-DR- J Immunol 149: 2130, 1992.
15. Czech W, Krutmann J, Budnik A, Schopf E, Kapp A. Induction of intercellular adhesion molecule I (ICAM-1) expression in normal human eosinophils by inflammatory cylokines. J Invest Dermatol 100: 417. 1993.
16. Hossain M, Okubo Y, Horie S, Sekiguchi M. Analysis of recombinant human tumour necrosis faclor-a-induced CD4 expression on human eosinophils. Immunology 88: 301, 1996.
17. Okubo Y, Hossain M, Kai R, et al. Adhesion molecules on eosinophils in acute eosinophilic pneumonia. Am J Respir Crit Care Med 151: 1259, 1995.
18. Bradley BL, Azzawi M, Jacobson M, et al. Eosinophits. T-tymphocytes. mast cells, neutrophils and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 88: 661, 1991.
19. Gleich GJ, Flavahan NA, Fujisawa T, Vanhoutte PM. The eosinophil as a mediator of damage to respiratory epithelium, a model for bronchial hyperreactivity. J Allergy Clin Immunol 81: 776, 1988.
20. Hatzelmann A, Tenor H, Schudt C. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil func- tions. Br J Pharmacol 114: 821, 1945.
21. Torphy TJ, Lindem BJ. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 46: 512, 1991.
22. Eldon MA, Battle MM, Coon MJ, Nordhlom CD, Sedman AJ, Colburn WA. Clinical pharmacokinetics and relative bioavailability of oral procaterol. Pharm Res 10: 603, 1993.
23. 2adrenergic bronchodilator in conscious guinea pigs. Arerugi Japanese Journal of Allergology (Tokyo) 34: 999, 1985.
24. Eda R, Sugiyama H, Hopp RJ, Okada C, Bewtra AK, Townley RG. Inhibitory effects of formoterol on platelet-activating factor induced eosinophil chemotaxis and degranulation. Int Arch Allergy Immunol 102: 391, 1993.
25. Kroegel C, Giembycz MA, Barnes PJ. Characterisation of eosinophil cell activation by peptides. Differential effects of substance P. melittin, and FMET-Leu-Phe. J Immunol 145: 2581. 1990.
26. Barclay J, Whiting B, Meredith PA, Addis GJ. Theophylline-salbutamol interaction: bronchodilator response to salbutamol at maximally effective plasma thcophylline concentrations. Br J Clin Pharmacol 11: 203, 1981.
27. Poher JS, Slowik MR, De Luca LG, Ritchie AJ. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endolhelial leukocyle adhesion molecule-1, and vascular cell adhesion molecule-1, bul not intercellular adhesion molecule-1. J Immunol 150: 5114, 1993.
28. Walker C, Rihs S, Braun RK, Betz S, Bruijnzeel PL. Increased expression ot CD11b and functional changes in eosinophils after migration across endothelial cell monolayers. J Immunol 150: 4061, 1993.
29. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol 94: 427, 1994.
30. Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J. Antiinflammatory effect of low-dose oral theophylline in atopic asthma. Lancet 343: 1006, 1994 (published erratum appears in Lancet 343: 1512, 1994).
31. Banner KH, Page CP. Theophylline and selective phosphodiesterase inhibitorsas anti-inflammatory drugs in the treatment of bronchial asthma. Eur Respir J 8: 996, 1995.
32. Kidney J, Dominguez M, Taylor PM, Rose M, Chung KF, Barnes PJ. Immunomodululion by theophylline in asthma. Demonstration by withdrawal of therapy. Am J Respir Cril Care Med 151: 1907, 1995.